Literature DB >> 17883327

Chemokines and their receptors: drug targets in immunity and inflammation.

Antonella Viola1, Andrew D Luster.   

Abstract

The chemokine system coordinates leukocyte migration in immunity and inflammation and is implicated in the pathogenesis of many human diseases. Although several successful strategies have been identified to develop drugs targeting chemokines and their receptors, this has not yet resulted in many new therapeutics. This is likely due to a complexity of the chemokine system, which was not initially appreciated, that is characterized by redundancy, pleiotropy, and differences among species. Nevertheless, our understanding of chemokine biology is continuing to grow and several promising drugs are currently being tested in late-stage clinical trials. In this review, we examine the role of chemokines in health and diseases and discuss strategies to target the chemokine system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17883327     DOI: 10.1146/annurev.pharmtox.48.121806.154841

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  205 in total

1.  Protective effect of eotaxin-2 inhibition in adjuvant-induced arthritis.

Authors:  J N Ablin; M Entin-Meer; V Aloush; S Oren; O Elkayam; J George; I Barshack
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

2.  The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis.

Authors:  Jieer Ying; Qi Xu; Gu Zhang; Bixia Liu; Liming Zhu
Journal:  Med Oncol       Date:  2011-06-01       Impact factor: 3.064

Review 3.  CXCR4-based imaging agents.

Authors:  Lauren E Woodard; Sridhar Nimmagadda
Journal:  J Nucl Med       Date:  2011-11       Impact factor: 10.057

4.  Fractalkine receptor CX(3)CR1 is expressed in epithelial ovarian carcinoma cells and required for motility and adhesion to peritoneal mesothelial cells.

Authors:  Mijung Kim; Lisa Rooper; Jia Xie; Andre A Kajdacsy-Balla; Maria V Barbolina
Journal:  Mol Cancer Res       Date:  2011-11-07       Impact factor: 5.852

5.  Increased expression of CC chemokine ligand 18 in patients with chronic rhinosinusitis with nasal polyps.

Authors:  Sarah Peterson; Julie A Poposki; Deepti R Nagarkar; Regina T Chustz; Anju T Peters; Lydia A Suh; Roderick Carter; James Norton; Kathleen E Harris; Leslie C Grammer; Bruce K Tan; Rakesh K Chandra; David B Conley; Robert C Kern; Robert P Schleimer; Atsushi Kato
Journal:  J Allergy Clin Immunol       Date:  2011-09-23       Impact factor: 10.793

6.  Molecular requirements for inhibition of the chemokine receptor CCR8--probe-dependent allosteric interactions.

Authors:  P C Rummel; K N Arfelt; L Baumann; T J Jenkins; S Thiele; H R Lüttichau; A Johnsen; J Pease; S Ghosh; R Kolbeck; M M Rosenkilde
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

7.  Gating function of isoleucine-116 in TM-3 (position III:16/3.40) for the activity state of the CC-chemokine receptor 5 (CCR5).

Authors:  A Steen; A H Sparre-Ulrich; S Thiele; D Guo; T M Frimurer; M M Rosenkilde
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 8.  Chemokines in the immunopathogenesis of hepatitis C infection.

Authors:  Mathis Heydtmann; David H Adams
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

9.  Death Receptor 3 Promotes Chemokine-Directed Leukocyte Recruitment in Acute Resolving Inflammation and Is Essential for Pathological Development of Mesothelial Fibrosis in Chronic Disease.

Authors:  William V Perks; Ravinder K Singh; Gareth W Jones; Jason P Twohig; Anwen S Williams; Ian R Humphreys; Philip R Taylor; Simon A Jones; Eddie C Y Wang
Journal:  Am J Pathol       Date:  2016-09-21       Impact factor: 4.307

Review 10.  Mechanistic systems biology of inflammatory gene expression in airway smooth muscle as tool for asthma drug development.

Authors:  Chi-Ming Hai
Journal:  Curr Drug Discov Technol       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.